Abstract
Bisphosphonates are indicated for the treatment of bone metabolic and neoplastic diseases aiming to control bone resorption. These drugs show high affinity to mineral tissues and are released after traumatic or inflammatory stimuli. Since released, they act by inhibiting osteoclast maturation and inducing apoptosis of these cells. The installation of oral implants in patients on bisphosph…